Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

Peer Review reports

Original Submission
12 Jan 2022	Submitted	Original manuscript
13 Feb 2022	Reviewed	Reviewer Report
10 Apr 2022	Reviewed	Reviewer Report
28 Apr 2022	Author responded	Author comments - Scott W Klarenbach
Resubmission - Version 2
28 Apr 2022	Submitted	Manuscript version 2
29 Apr 2022	Author responded	Author comments - Scott W Klarenbach
Resubmission - Version 3
29 Apr 2022	Submitted	Manuscript version 3
13 May 2022	Reviewed	Reviewer Report
31 May 2022	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
17 Jun 2022	Editorially accepted
2 Jul 2022	Article published	10.1186/s12888-022-04075-y

Back to article page